111
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Retrospective comparison of different percutaneous approaches to manage occluded primary uncovered self-expandable metal stents in patients with unresectable malignant hilar biliary obstruction

, , , , ORCID Icon &
Pages 1397-1402 | Received 28 Aug 2019, Accepted 13 Oct 2019, Published online: 26 Oct 2019

References

  • van Delden OM, Lameris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol. 2008;18(3):448–456.
  • Rerknimitr R, Angsuwatcharakon P, Ratanachu-Ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28(4):593–607.
  • Dong JS, Dong IG, Han K, et al. Percutaneous metallic stent placement for palliative management of malignant biliary hilar obstruction. Korean J Radiol. 2018;19:597–605.
  • Walter T, Ho CS, Horgan AM, et al. Endoscopic or percutaneous biliary drainage for Klatskin tumors? J Vasc Interv Radiol. 2013;24(1):113–121.
  • Zhao XQ, Dong JH, Jiang K, et al. Comparison of percutaneous transhepatic biliary drainage and endoscopic biliary drainage in the management of malignant biliary tract obstruction: a meta-analysis. Dig Endosc. 2015;27(1):137–145.
  • Woohyun P, Youngsoo P, Jinhyeok H, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc. 2009; 69:55–62.
  • Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–298.
  • Li M, Li K, Qi X, et al. Percutaneous Transhepatic biliary stent implantation for obstructive jaundice of perihilar cholangiocarcinoma: a prospective study on predictors of stent patency and survival in 92 patients. J Vasc Interv Radiol. 2016;27(7):1047–1055.
  • Nennstiel S, Tschurtschenthaler I, Neu B, et al. Management of occluded self-expanding biliary metal stents in malignant biliary disease. Hepatob Pancreat Dis Int. 2018;17(1):49–54.
  • Ito K, Ogawa T, Horaguchi J, et al. Reintervention for occluded biliary metal stent for patients with malignant distal biliary stricture. Dig Endosc. 2013;25:126–131.
  • Togawa O, Isayama H, Tsujino T, et al. Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstruction. J Gastroenterol. 2013;48(11):1300–1307.
  • Katsinelos P, Beltsis A, Chatzimavroudis G, et al. Endoscopic management of occluded biliary uncovered metal stents: a multicenter experience. World J Gastrointest Endosc. 2011;17(1):98–104.
  • Isayama H, Hamada T, Yasuda I, et al. TOKYO criteria 2014 for transpapillary biliary stenting. Dig Endosc. 2015;27(2):259–264.
  • Cardella JF, Kundu S, Miller DL, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20(7):S189–S191.
  • Dumonceau JM, Tringali A, Blero D, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy. 2018;50:910–930.
  • Ridtitid W, Rerknimitr R. Management of an occluded biliary metallic stent. World J Gastrointest Endosc. 2012;4(5):157–161.
  • Perez-Johnston R, Deipolyi AR, Covey AM. Percutaneous biliary interventions. Gastroenterol Clin N Am. 2018;47(3):621–641.
  • Mok K, Wang B, Chang H, et al. External biliary drainage plus bile acid feeding is not equal to internal drainage in preserving the cellular immunity following prolonged obstructive jaundice. Dig Dis Sci. 2001;46(9):1864–1870.
  • Sellier F, Bories E, Sibertin-Blanc C, et al. Clinical outcome after biliary drainage for metastatic colorectal cancer: survival analysis and prognostic factors. Dig Liver Dis. 2018;50(2):189–194.
  • Riaz A, Pinkard JP, Salem R, et al. Percutaneous management of malignant biliary disease. J Surg Oncol. 2019;120(1):45–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.